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Dietary components in early life play a role in both microbiota and intestinal immune
system maturation in mammalian species. Adipokines, as endogenously produced
hormones from breast milk, may have an impact on this process. The aim of the
present study was to establish the influence of leptin and adiponectin supplementation
during suckling on the intraepithelial lymphocyte composition, intestinal barrier function,
intestinal gene expression, and gut microbiota in rat. For this purpose, newborn
Wistar rats were supplemented daily with leptin, adiponectin, or whey protein
concentrate during the first 21 days of life. Lymphocyte composition was established
by immunofluorescence staining and flow cytometry analysis; intestinal gene expression
by real-time PCR and cecal microbiota were analyzed through 16S rRNA gene
sequencing. Although leptin and adiponectin were able to increase the Tc TCRαβ+
and NKT cell proportion, they decreased the NK cell percentage in IEL. Moreover,
adipokine supplementation differentially modified CD8+ IEL. While the supplementation
of leptin increased the proportion of CD8αα+ IEL (associated to a more intestinal
phenotype), adiponectin enhanced that of CD8αβ+ (related to a peripheral phenotype).
Furthermore, both adipokines enhanced the gene expression of TNF-α, MUC-2, and
MUC-3, and decreased that of FcRn. In addition, the adipokine supplementations
decreased the abundance of the Proteobacteria phylum and the presence of Blautia.
Moreover, leptin-supplemented animals had lower relative abundance of Sutterella and
a higher proportion of Clostridium genus, among others. However, supplementation
with adiponectin resulted in lower abundance of the Roseburia genus and a higher
proportion of the Enterococcus genus. In conclusion, the supplementation with leptin and
adiponectin throughout the suckling period had an impact on both the IEL composition
and the gut microbiota pattern, suggesting a modulatory role of these adipokines on the
development of intestinal functionality.
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INTRODUCTION
The intestinal microbiota develops in early life and although the
microbiota colonizes the intestine mainly after birth, over the
years the opinion about when the colonization starts has been
changing (1). In the past, it was considered that the in utero
environment was sterile and it was not until delivery that
colonization began, when the newborn passed through the vagina
or skin (Cesarean section) and adopted maternal microbiota (2).
However, latest studies have shown that bacteria may already
start their colonization during pregnancy, since microbiota have
been found to present in the placenta or amniotic fluid, and have
even been isolated in the meconium (2–4). It is also suggested
that the placenta has its own microbiota (5). Despite all the
factors affecting the gut microbiome in utero, the main factor
shaping the gut ecosystem after birth is diet, when bacteria are
transferred to the infant through breast milk and later with the
introduction of solid food (1). The process of gut colonization
in newborns sets the stage for adults’ microbiome and its
dysregulation in early life could affect health thereafter (6).
Intestinal microbiota composition during the first year of
life differs from that present in adults, it is less stable,
more variable in its composition and has low diversity (7,
8). At birth, the newborn’s gut has an aerobic environment,
where mainly facultative anaerobes such as Enterobacteriaceae
or Staphylococcus can colonize (9, 10). Some days after, the
growth of Bifidobacterium, Clostridium, and Bacteroidetes, strict
anaerobe bacteria, appear due to the conversion of the intestine
to an anaerobic environment (11). Until weaning, the microbiota
depends on the diet of the infant, thus breastfed infants
have Bifidobacteria as dominant genus, whereas formula-fed
newborns show an increase in the Enterobacteria (2). When solid
food is introduced, the microbiota suffers another important
change and it turns toward adult-like microbiota, presenting
an increase in the abundance of Bacteroides, Clostridium,
Ruminococcus, and Prevotella (9, 10). Moreover, there are other
different factors that influence the intestinal microbiota of the
newborn, such as the gestational age, the birth weight, gender of
the baby, mode of delivery, location of birth (home or hospital),
geographic location, hospitalization of the newborn, maternal
and/or infant use of antibiotics, probiotics or prebiotics; finally,
the size of the family or the presence of pets at home could
modulate it (12).
Microbiota plays an important role in the maturation of the
immune system, mainly with those lymphocytes present in the
gut-associated lymphoid tissue (GALT) (9). At birth, GALT is not
fully mature and it is still developing during suckling (13). In the
epithelium of the intestinal mucosa are located the intraepithelial
lymphocytes (IEL), which are the first immune cells in contact
with intestinal antigens, protecting the gut from infections (14).
The importance of the crosstalk between the colonizing bacteria
and the underlying lymphoid cells is well-known (15). If there
is not a good development of the GALT or a good intestinal
colonization by the microbiota, this communication is lost and
makes the baby more susceptible to infections (15, 16).
Human milk provides a high number of bioactive factors
that promote the formation of innate and adaptive immune
factors, such as lactoferrin, cytokines, growth factors, adipokines,
secretory immunoglobulin A (sIgA), among others. These
components protect the infant against infections and promote
their immune systemmaturation (17). Moreover, breast milk also
contains bacteria from the mother’s gut and some compounds,
such as prebiotic oligosaccharides, which also participate in
the microbiota’s development (18). In previous studies, we
have described the role of leptin and adiponectin, adipokines
present in breast milk, in the maturation of the early life
immune system, particularly in systemic immune response (19)
and also in the inductive GALT (20). In line with this, we
hypothesized that these adipokines could also influence the
effector GALT, the gut microbiota and also their interaction,
promoting the development in this first stage of life. Thus, the
purpose of this paper is to study the influence of leptin and
adiponectin supplementation on the IEL composition, intestinal
gene expression and microbiota pattern in suckling rats.
MATERIALS AND METHODS
Animals
Pregnant Wistar rats (G15) were obtained from Janvier Labs
(Le Genest Saint Isle, France). Dams were housed in individual
cages and fed with commercial diet corresponding to the
American Institute of Nutrition 93M formulation (Harlan
Teklad, Madison, Wisconsin, USA) and water ad libitum. The
animals were maintained under controlled temperature and
humidity conditions in a 12:12 h light:dark cycle in the animal
facilities of the Faculty of Pharmacy and Food Science. The
gestating rats were monitored daily and allowed to deliver at
term. Proportion of males and females were between 40 and
60% in each litter. The day after birth was registered as day
1 of life. Litters were unified to 9 pups per lactating dam and
had free access to the breast milk and rat diet. Daily, pups were
separated from their mother, to be identified, weighted, and
orally administered. To avoid the influence of biological rhythms,
handling was done in the same time range.
With regard to sample size estimation, because of the
variability among litters, four litters were required for each group.
This calculation was made by the Appraising Project Office’s
program from the Universidad Miguel Hernández de Elche
(Alicante), used to provide statistically significant differences
among groups, assuming that there is no dropout rate and
considering a type I error of 0.05 (two-sided). The studies
were performed in accordance with the criteria outlined by
the Guide for the Care and Use of Laboratory Animals.
Experimental procedures were reviewed and approved by the
Ethical Committee for Animal Experimentation of the University
of Barcelona and the Ethical Committee of the Generalitat de
Catalunya (CEEA/UB 220/15 and DAAM: 8521).
Dietary Supplementation
Suckling rats were randomly distributed into four groups,
according to the oral supplementation received: the Reference,
the Leptin, the Adiponectin, and the Whey Protein Concentrate
(WPC) groups. Each group was constituted by four different
litters (n = 36 pups/group). Animals from the Reference
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group were administered with the same volume of vehicle
(mineral water) as the supplemented groups (10 mL/kg/day).
The Leptin group was supplemented with a solution of leptin
(PeproTech R©, Rocky Hill, NJ, USA) at a dose of 0.7 µg/kg/day
in mineral water, the Adiponectin group was supplemented with
adiponectin (PeproTech R©) solution at a dose of 35 µg/kg/day
in mineral water and the WPC group was supplemented with
Lacprodan R© MFGM-10 (Arla Foods Ingredients Group, Diby,
Denmark) at a dose of 0.3 g/kg/day in mineral water. All
these doses have been demonstrated in previous studies to
have immunomodulatory activity (19, 20). The WPC group was
used as positive control of modulation by breast milk bioactive
factors. Suckling rats were daily supplemented during the whole
lactating period (21 days), using low-capacity syringes (Hamilton
Bonaduz, Bonaduz, Switzerland) adapted to oral 25- or 23-
gauge gavage tubes and 27mm in length (ASICO, Westmont, IL,
USA), as previously described (21). To allow gastric emptying,
litters were separated from their dams half an hour before
oral supplementation.
Experimental Design 1
Onday 10 -in themiddle of the suckling period-, the functionality
of the intestinal epithelial barrier was assessed on 3 rats of
each litter (n = 12/group) by an in vivo permeability assay, as
previously described (22). Briefly, a solution of 4 kDa-dextran
conjugated to FITC (Sigma-Aldrich) was orally administered
to rats using low-capacity syringes adapted to oral gavage
tubes. There was an additional group of animals that was only
administered with an equivalent volume of PBS (10 mL/kg) to
rule out the fluorescent background of the plasma samples. After
4 h of the dextran administration, the animals were euthanized
and plasma was obtained, diluted and the fluorescence emission
was quantified by triplicate at an excitation wavelength of
490 nm in theModulusTM microplate spectrophotometer (Turner
Biosystems, Sunnyvale, CA, USA). Moreover, a 0.5 cm portion of
the middle intestine was immediately conserved in RNAlater R©
(Applied Biosystems, Weiterstadt, Germany), incubated at 4◦C
overnight and stored at−20◦C until PCR analysis.
Experimental Design 2
At the end of the suckling period (day 21), another 3 rats of
each litter (n= 12/group) were anesthetized intramuscularly with
ketamine (90mg/kg) (Merial Laboratories S.A., Barcelona, Spain)
and xylazine (10 mg/kg) (Bayer A.G., Leverkusen, Germany),
exsanguinated and the small intestine was carefully collected.
After discarding the duodenum, a 0.5 cm portion of the middle
intestine was immediately conserved, as previously on day 10,
until PCR analysis. The proximal 1/3 portion of the intestine
was opened lengthwise along the mesenteric line and was cut
into 2 cm pieces and immersed in Hanks balanced salt solution
(HBSS) (Sigma-Aldrich, Madrid, Spain) supplemented with 100
IU/mL streptomycin–penicillin (Sigma-Aldrich) and 5% fetal
bovine serum (FBS; Sigma-Aldrich) until further steps in IEL
isolation. Moreover, cecal content was also collected and kept at
−80◦C for gut microbiota analysis.
Intraepithelial Lymphocyte Isolation
IEL suspensions were obtained following procedures previously
established in our laboratory (23), with some modifications.
Briefly, small pieces of intestine were incubated with a 1mM
1,4-dithiothreitol (DTT) (Sigma-Aldrich) solution in HBSS with
10% FBS under continuous agitation (55 u/min, 20min, 37◦C).
The first supernatants were collected by decanting the tubes.
Afterwards, a 5mM ethylenediaminetetraacetic acid (EDTA)
(Sigma-Aldrich) solution inHBSS with 10% FBSwas added to the
remaining intestinal tissue and incubated twice under continuous
agitation (55 u/min, 15min, 37◦C). The supernatants from each
step were decanted from the tissue pieces, collected and then
centrifuged (538 g, 5min, 4◦C). The resulting pellet containing
IEL and epithelial cells from all steps was then subjected to
IEL purification.
Intraepithelial Lymphocyte Purification
The pellet containing IEL was resuspended in 44% Percoll R©
(Sigma-Aldrich). Each cell suspension was overlaid on 67.5%
Percoll R© and, after centrifugation (600 g, 30min, room
temperature), viable lymphocytes were recovered from the
interface. Finally, purified lymphocytes were resuspended
in Roswell Park Memorial Institute (RPMI) 1640 medium
(Sigma-Aldrich) enriched with 10% FBS, 100 IU/mL
streptomycin–penicillin, 2mM L-glutamine (Sigma-Aldrich)
and 0.05mM 2-β-mercaptoethanol (Merck Millipore). Cell
number and viability were determined using CountessTM
Automated Cell Counter (InvitrogenTM, Thermo Fisher
Scientific, Barcelona, Spain).
Immunofluorescence Staining and Flow
Cytometry Analysis
IEL (2 × 105) were stained with anti-rat monoclonal antibodies
(mAb) conjugated to fluorescein isothiocyanate (FITC),
phycoerythrin (PE), peridininchlorophylla protein (PercP),
allophycocyanin (APC) or APC-cyanine (Cy)7, as in previous
studies (24). In this case, the mAb used were anti-CD4, anti-
CD8α, anti-CD8β, anti-TCRαβ, anti-TCRγδ, anti-NKR-P1A,
anti-CD25, anti-CD45RA (BD Biosciences, San Diego, USA),
anti-CD62L, and anti-CD103 (Biolegend, San Diego, CA,
USA). After standard procedures (20), samples were analyzed
using a GalliosTM Cytometer (Beckman Coulter Inc., Miami,
FL, USA) in the Scientific and Technological Centers of the
University of Barcelona (CCiT-UB). The results were assessed
by FlowJo version 10 software (TreeStar, Inc., Ashland, OR,
USA). Lymphocyte subsets were defined as follows: Th (TCRαβ+
NKR-P1A− CD4+) cells; Tc TCRαβ+ (TCRαβ+ NKR-P1A−
CD8+) cells; Tc TCRγδ+ (TCRγδ+ CD8+) cells; natural killer
(NK) (NKR-P1A+ TCRαβ−) cells; NKT (NKR-P1A+ TCRαβ+)
cells; CD4+ (CD4+ CD8−) cells; CD8+ (CD4− CD8+) cells;
CD8αα+ (CD8α+ CD8β−); CD8αβ+ (CD8α+ CD8β+). Results
are expressed as percentages of positive cells in the lymphocyte
population selected according to their forward-scatter cells
(FSC) and side-scatter characteristics (SSC) or in a particular
selected population.
Frontiers in Immunology | www.frontiersin.org 3 October 2019 | Volume 10 | Article 2369
Grases-Pintó et al. Adipokines Influence Suckling Rat GALT and Microbiota
Quantification of Gene Expression in Small
Intestine
For RNA isolation, small intestine samples from 6 rats/group
randomly selected conserved in RNAlater R© were processed as
in previous studies (25). Tissue samples were homogenized in
a FastPrep (MP Biomedicals, Illkirch, France) for 30 s. RNA
was obtained using a RNeasy Mini Kit (Qiagen, Madrid, Spain)
following the manufacturer’s instructions. RNA purity and
concentration were determined by NanoPhotometer (BioNova
Scientific, S.L. Fremont, CA, USA). Thereafter, cDNA was
obtained using TaqMan R© Reverse Transcription Reagents
(Applied Biosystems).
The specific PCR TaqMan R© primers (Applied Biosystems)
used to perform the PCR quantitative assay were: Tlr2
[Rn02133647_s1, inventoried (I)], Tlr4 (Rn00569848_m1, I),
Tlr5 (Rn04219239_s1, I), Tlr7 (Rn01771083_s1, I), Tlr9
(Rn01640054_m1, I), Infg (Rn00594078_m1, I), Tnf
(Rn99999017_m1, I), Il10 (Rn00563409_m1, I), Muc2
(Rn01498206_m1, I), Muc3 (Rn01481134_m1, I), Prdm1
(Rn03416161_m1, I, encoding for Blimp-1), Fcgrt
(Rn00583712_m1, I, encoding for FcRn), Pigr (Rn00562362_m1,
I), Cldn2 (Rn02063575_s1, I), Cldn4 (Rn01196224_s1, I), Ocln
(Rn00580064_m1, I), and Tjp1 (Rn02116071_s1, I, ZO-1).
Quantification of the studied genes was normalized to the
Gusb (β-glucuronidase, Rn00566655_m1, I) housekeeping gene,
which showed constant level of expression in our experimental
conditions and a similar level of expression to the studied genes.
Real-time PCR assays were performed in duplicate using an ABI
Prism 7900HT sequence detection system (Applied Biosystems).
The SDS software (version 2.4, Applied Biosystems) was used to
analyze the expression of data.
The amount of target mRNA relative to the endogenous
control expression was calculated for the three nutritional
intervention groups relative to values from the Reference group,
which represents 100% of the gene expression using the 2−11Ct
method, as previously described (26). Results are expressed as
percentage of values of each supplemented group normalized to
the mean value obtained for the Reference group, which was set
at 100%.
DNA Extraction
Cecal DNA was extracted using the QIAamp DNA Stool
Mini Kit (Qiagen), as previously described (27). The protocol
from the manufacturer was followed with an addition of
a bead beating step. Sterile glass beads (sized 1mm Ø)
were added together with stool lysis buffer to the samples
and cell lysis was performed for 4min at 25Hz using a
TissueLyser (Qiagen), followed by a heating step at 95◦C
for 5min. After lysis, DNA-damaging substances and PCR
inhibitors were neutralized using an InhibitEX tablets (provided
with the kit) and the DNA was purified on QIAamp Mini
spin columns.
PCR Amplification of the V4 Region of
Bacterial 16S rRNA Genes
The V4 region of 16S rRNA gene was amplified by PCR with
forward and reverse primers according to Kozich et al. (28),
containing Illumina (Illumina Inc., San Diego, CA, USA) adapter
sequences and unique dual indexes used to tag each PCR product,
according to the 16S-protocol provided by Illumina. Primer
sequences can be found in Table 1. Briefly, PCR was carried out
in 25µL reactions with 0.2µM forward and reverse primers, with
12.5 ng template DNA and 12.5 µL of 2 × KAPA HiFi HotStart
Ready Mix kit (KAPA Biosystems, Woburn, MA, USA). Thermal
cycling consisted of initial denaturation at 95◦C for 3min
followed by 25 cycles of denaturation at 95◦C for 30 s, annealing
at 55◦C for 30 s, and extension at 72◦C for 30 s, followed by a final
step of 72◦C for 5min. The amplicon products were purified with
Agencourt AMPureXP Kit (Beckman Coulter, Miami, FL, USA).
Next, a second PCR was thereafter performed to attach Illumina
adapters and unique dual indexes to each sample, followed by
a clean-up step with AmPureXP Kit (Beckman Coulter). PCR
amplicons were visualized using 0.1% agarose gel electrophoresis
to verify the size of the amplicon. Negative extraction controls
did not produce visible bands.
Amplicons Quantitation, Pooling, and
Sequencing
Amplicon DNA concentrations were quantified using the
Qubit4.0 Fluorometer (Life Technologies, Stockholm, Sweden).
Amplicons were combined in equimolar ratios into a single tube
with a final concentration of the DNA library of 4 pM. As an
internal control, 5% of PhiX was added to the amplicon pool.
Paired-end sequencing with a read length of 2 × 250 bp was
carried out on a Miseq Instrument (Illumina) using a Miseq
reagent kit v2 (Illumina).
Sequence Analysis
Sequenced data were analyzed with an open-source
bioinformatics pipeline Quantitative Insights into Microbial
Ecology (QIIME), which allows the analysis of high-throughput
community sequencing data. Sequences were removed when
lengths were <200 nucleotides, contained ambiguous bases,
primer mismatches or if the homo polymer runs were in excess
of six bases. After quality filtering, a total of 3,913,202 reads
were obtained for the 29 samples with an average of 134,938
reads per sample (min: 64,101 and max: 232,472). Similar
sequences were binned into operational taxonomic units (OTU)
TABLE 1 | Primer sequences for amplification of V4 region of 16S rRNA gene.
515f Forward primer with Illumina overhang adaptor (underlined) 5′TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTGCCAGCMGCCGCGGTAA
806r Reverse primer with Illumina overhang adaptor (underlined) 5′GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGACTACHVGGGTWTCTAAT
The underlined part represents the adapters for Illunima MiSeq instrument.
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using UCLUST, with a minimum of 97% sequence similarity.
The most abundant sequence in each OTU was chosen to
represent the respective OTU. Then, representative sequences
(most abundant) from each OTU were aligned using Python
Nearest Alignment Space Termination (PyNAST). Taxonomy
was assigned using Greengenes database (v.13_8). The heat map
of the mean relative abundances of genera was also obtained
from QIIME. In addition, the relative proportion of the bacteria
was calculated using GraphPad Prism software (version 7.0,
GraphPad Software, La Jolla, CA, USA). Finally, Venn diagrams
were made by Bioinformatics and Evolutionary Genomics
program from the University of Ghent.
Statistical Analysis
The software IBM Statistical Package for the Social Sciences
(SPSS, version 22.0, Chicago, IL, USA) was used to perform
statistical analysis. Levene’s and Shapiro–Wilk tests were applied
to assess variance equality and normal distribution, respectively.
Conventional one-way ANOVA test was performed considering
the experimental group as the independent variable. When
supplementation had a significant effect on the dependent
variable, Bonferroni post-hoc test was applied. Otherwise, non-
parametric Kruskal–Wallis test followed by the post-hoc Mann–
Whitney U-test were used in order to assess significance for
independent and related samples, respectively. A parallel analysis
was performed taking into account the sex of the animals as
variable. As no sexual dimorphism in the variables analyzed here
in the early life animal was found, animals in each group were
considered together independently of sex. Significant differences
were accepted when p < 0.05.
RESULTS
Intestinal Barrier Function
To study the intestinal epithelial barrier function on day 10,
when it is still in early development, an in vivo permeability
assay was performed to determine the paracellular pass of the
4 kDa-dextran labeled with FITC. No effect due to any of the
supplementations was found, suggesting that the compound
tested do not act through the modulation of such function
(Supplementary Figure 1A).
Intraepithelial Lymphocyte Composition
The percentage of the main subsets present in IEL was
determined at day 21 (Figure 1). After the supplementation,
during the whole suckling period, both leptin and adiponectin
were able to increase the Tc TCRαβ+ and NKT proportions
and to decrease NK cell percentage in IEL compared to the
Reference group (p < 0.05, Figure 1). The WPC group showed
the same effect (p < 0.01), indicating that the effect of the
adipokines on the IEL population is in line with that of the whey
protein, containing a high concentration of bioactive factors
with immunomodulatory effects. No changes due to diets were
observed in Th or Tc TCRγδ+.
With regard to the CD8 co-receptor, all components enhanced
its presence after 21 days of supplementation (p < 0.01 vs.
Reference group, Figure 2A). However, leptin and adiponectin
differentially modulated CD8+ IEL development. Changes
FIGURE 1 | Main IEL subsets at day 21 from the four groups: Reference,
Leptin, Adiponectin, and Whey Protein Concentrate (WPC). Lymphocyte
populations were defined as follows: Th (TCRαβ+ NKR-P1A− CD4+) cells; Tc
TCRαβ+ (TCRαβ+ NKR-P1A− CD8+) cells; Tc TCRγδ+ (TCRγδ+ CD8+) cells;
NKT (NKR-P1A+ TCRαβ+) cells; and natural killer (NK) (NKR-P1A+ TCRαβ−)
cells. Results are expressed as mean ± S.E.M. (n = 8–12 pups). Statistical
differences: *p < 0.05 vs. Reference group, 1p < 0.05 vs. Leptin group.
induced by leptin supplementation were associated with an
increase in a more intestinal phenotype (CD8αα+) (p < 0.05 vs.
Reference group), whereas adiponectin or WPC administration
was related with amore peripheral phenotype (CD8αβ+, p< 0.05
vs. Reference and Leptin group, Figure 2A). These alterations
caused higher CD8αα+/CD8αβ+ ratio in animals supplemented
with leptin compared to reference (p < 0.05, Figure 2B).
Furthermore, the expression of intestinal homing molecules
(αE integrin and CD62L selectin) and the activation marker
CD25 was also studied (Figure 2C). None of the dietary
interventions during 21 days was able to modify the expression
of any of the three molecules.
Intestinal Gene Expression
The relative gene expression in the intestine of molecules
associated with the bacteria host cell crosstalk [Toll-like
receptor (TLR)-2, TLR-4, TLR-5, TLR-7, TLR-9], innate immune
response [tumor necrosis factor (TNF)-α, mucin (MUC)-2,
MUC-3], intestinal maturation and function [B-lymphocyte-
induced maturation-protein-1 (Blimp-1), neonatal-Fc-receptor
(FcRn), polymeric Ig receptor (pIgR)], and molecules related to
tight junctions of the epithelial barrier [Claudin-4, Occludin,
zona occludens (ZO)-1], are shown in Figure 3. Moreover, other
molecules such as interferon (IFN)-γ, interleukin (IL)-10, and
Claudin-2 were also studied without reaching levels of detection.
With regard to the TLR expression, although no changes
were observed in TLR-4 and TLR-9 (Figures 3B,E, respectively),
adiponectin supplementation, but not leptin, showed a tendency
to decrease TLR-7 (Figure 3D) and significantly decreased TLR-
2 and TLR-5 gene expression (p < 0.05 vs. Reference, Leptin and
WPC groups, Figures 3A,C).
Focusing on molecules related to the intestinal innate
immune response, TNF-α, MUC-2, and MUC-3, their gene
expression was higher in those suckling rats supplemented
with both adipokines (p < 0.05, Figures 3F–H), suggesting
a role in the early development of innate immunity. These
changes were already observed only for MUC-2 on day 10
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FIGURE 2 | CD8+ IEL subsets (A,B) and surface expression of some molecules in IEL (C) at day 21 from the four groups: Reference, Leptin, Adiponectin, and Whey
Protein Concentrate (WPC). Percentage of CD8+ (CD8+ CD4−); CD8αα+ (CD8α+ CD8β−); and CD8αβ+ (CD8α+ CD8β+) (A). The ratio CD8αα+/CD8αβ+ (B).
Percentage of αE+ integrin (CD103+), CD62L+ selectin, and CD25+ IEL (C). Results are expressed as mean ± S.E.M. (n = 8–12 pups). Statistical differences:
*p < 0.05 vs. Reference group, 1p < 0.05 vs. Leptin group.
(P < 0.05, Supplementary Figure 1B). In addition, leptin
dietary intervention promoted intestinal maturation by means
of enhancing the Blimp-1 gene expression (p < 0.01, Figure 3I).
Moreover, both adipokine supplementations during 21 days
lowered the expression of FcRn gene (p< 0.05, Figure 3J). On the
other hand, none of the three compounds were able to modify the
gene expression of pIgR (Figure 3K) Neither Blimp-1 nor FcRn
gene expression was modified earlier in life due to the adipokines
supplementation (day 10, Supplementary Figure 1B).
Regarding the molecules related to the tight junctions of
the epithelial barrier, although no differences were detected on
day 10 (Supplementary Figure 1B), the animals supplemented
with adiponectin showed lower gene expression of ZO-1 (p
< 0.05 vs. Leptin group, Figure 3N). However, no differences
in Claudin-4 or Occludin due to adipokine supplementation
were observed on both studied days (Figures 3L,N and
Supplementary Figure 1B).
Gut Microbiota Composition
At the end of the study, cecal microbiota composition was
established. To assess the diversity of microbial populations,
Shannon-Wiener and CHAO1 indexes were calculated. None of
the four groups showed any significant change in the microbiota
diversity (Table 2). However, the dietary interventions influenced
the microbiota composition at different taxonomic levels.
The main phylum of bacteria present in the Reference
group was Bacteroidetes, followed by Firmicutes, Proteobacteria
and Cyanobacteria, and were approximately 47, 30, 19, and
3% of total gut microbiota, respectively (Figure 4A). The
three supplementations induced lower Proteobacteria phylum
proportion compared to the Reference group (p < 0.01,
Figure 4A). In the Leptin group, this decrease was due to the
lower abundance of Desulfovibrionaceae, Alcaligenaceae, and the
unclassified family from the RF32 order (p < 0.01 vs. Reference
group, Figure 4B). In the case of the Adiponectin group, this
change was caused only by a lower presence of the unclassified
family from the RF32 order (p < 0.01 vs. Reference group,
Figure 4B) and WPC also showed less Desulfovibrionaceae and
unclassified family from RF32 order than the Reference group
(p < 0.01, Figure 4B). The Firmicutes/Bacteroidetes ratio was
also assessed without changes observed among groups (Table 2).
Although no significant changes were observed in Bacteroidetes
and Firmicutes phylum proportions due to the interventions,
some modifications in their respective families were observed in
animals supplemented with leptin and WPC. In this sense, the
Leptin group had a higher proportion of Ruminococcaceae and
the unclassified family from the Clostridiales order (p < 0.01 vs.
Reference group, Figure 4B). On the other hand, an increase in
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FIGURE 3 | Gene expression in small intestinal samples from the four groups: Reference, Leptin, Adiponectin, and Whey Protein Concentrate (WPC). TLR-2 (A),
TLR-4 (B), TLR-5 (C), TLR-7 (D), TLR-9 (E), TNF-α (F), MUC-2 (G), MUC-3 (H), Blimp-1 (I), FcRn (J), pIgR (K), Claudin-4 (L), Occludin (M), and ZO-1 (N). Results
are expressed as mean ± S.E.M. (n = 6–12 pups). Statistical differences: *p < 0.05 vs. Reference group, 1p < 0.05 vs. Leptin group, ψp < 0.05 vs. Adiponectin
group, #p < 0.05 vs. WPC group.
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TABLE 2 | Shannon-Wiener and CHAO1 indexes from the four groups: Reference, Leptin, Adiponectin, and Whey Protein Concentrate (WPC) at the end of the suckling
period.
Reference Leptin Adiponectin WPC
Chao 1 190.00 ± 26.40 222.74 ± 42.86 213.00 ± 37.22 182.50 ± 20.66
Shannon 5.02 ± 0.17 5.04 ± 0.25 5.16 ± 0.34 4.76 ± 0.27
Firmicutes/Bacteroidetes ratio 0.58 ± 0.19 0.57 ± 0.19 0.67 ± 0.17 0.68 ± 0.09
The results are expressed as a mean ± S.E.M. (n = 9–12).
FIGURE 4 | The relative proportion of the bacteria was calculated for phylum (A) and family (B) at day 21 from the four groups: Reference, Leptin, Adiponectin, and
Whey Protein Concentrate (WPC) (n = 6–12 pups). Statistical differences: *p < 0.05 vs. Reference group.
the Prevotellaceae and Lactobacillaceae families and a decrease
in the Lachnospiraceae family proportions were observed in
those animals fed with WPC compared to the Reference group
(p < 0.05, Figure 4B).
The heatmap of Figure 5 shows the changes found at genus
level. The regions with a higher presence of a particular genus
are indicated in red and those with a lower presence in blue. All
supplementations were able to decrease the relative abundance of
Blautia genus of the cecal microbiota compared to the Reference
group (p < 0.01 for the Leptin and WPC groups and p < 0.05
for the Adiponectin group, Figure 5). Moreover, some specific
effects of each adipokine were observed. On the one hand, rats fed
with leptin showed a higher proportion of the Clostridium and
Dehalobacterium genera and a lower presence of theHoldemania
and Sutterella genera (p < 0.01 vs. Reference group). On the
other hand, an increase of the Enterococcus genus and a decrease
in the Roseburia and Allobaculum genera abundances were
observed in the Adiponectin group (p < 0.05). WPC nutritional
intervention promoted the presence of the Dehalobacterium
genus and reduced the relative abundance of the Anaerotruncus
and Adlercreutzia genera (p < 0.05, Figure 5).
In order to better understand the presence or the absence
of bacterial genera found in each group, Venn diagrams
were plotted (Figure 6). Among all cecal genera detected, 40
genera were present in the four groups studied. Nevertheless,
the supplementation with leptin promoted the specific
colonization with the Candidatus arthromitus species whereas
the Lactococcus genus appeared only after the supplementation
with WPC (Figure 6).
DISCUSSION
In previous studies, we demonstrated that a daily
supplementation with leptin or adiponectin during the whole
suckling period was able to enhance the immune system of
pups, not only in the intestinal compartment (20), but also
at systemic level (19). These results prompted us to further
study the influence of the supplementation of these adipokines
on the IEL subsets, as representative effector cells of GALT,
intestinal gene expression and cecal microbiota composition.
Moreover, as WPC has previously shown immunomodulatory
effects on neonatal rats, one of the groups received it as a
positive control of modulation by breast milk bioactive factors.
However, a limitation of the study is the adiponectin structure
used. Whereas, the most abundant form of adiponectin in
human milk is the high molecular weight multimer (29), we
have supplemented the rats with the monomeric form. However,
and although leptin and adiponectin plasmatic levels in pups
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FIGURE 5 | Heatmap showing the abundance of microbiota at genus level at day 21 from the four groups: Reference (R), Leptin (L), Adiponectin (A), and Whey
Protein Concentrate (WPC) (n = 6–12 pups). Intense blue and red shades indicate lower and higher relative abundances, respectively.
were not assessed after supplementation in this approach,
their intestinal absorption in rodents has previously been
described (30, 31).
First of all, on day 10 of the suckling period, the
intestinal barrier function was assessed, evaluating the intestinal
permeability to 4 kDa-dextran. No changes were observed due
to adipokine supplementations. This result in early life rats is in
contrast to that found in two different studies; in one of them
an increase in intestinal permeability after an intraperitoneal
injection of leptin in adult rats was found (32), and, on the
contrary, in an in vitro study a reduction in permeability was
observed (33). The variability in these results highlights the
importance of the type of approach (in vitro vs. in vivo) but also
the state of development of the animals (suckling vs. adult).
To our knowledge, this is the first study to report the effect
of adipokine supplementation on IEL composition. Although
no changes were observed in Th or Tc TCRγδ+ cells, the three
supplemented groups showed an increase of Tc TCRαβ+ and
NKT cell percentages compared with the Reference group. These
changes were also observed in our previous studies in other
immune compartments, where the supplementation with both
adipokines was able to enhance both subsets on the spleen (19)
and T TCRαβ+ cells on the mesenteric lymph nodes (MLN) (20),
suggesting an enhancement of immune maturation. However, a
decrease in the NK cell proportion was detected after the three
nutritional interventions in comparison to the Reference group.
As has been described, there is a physiological depletion in NK
IEL throughout the suckling period (13), and the enhancement
in the reduction could indicate a promotion of NK maturation
caused by the supplementations.
Regarding the proportion of cells bearing CD8, the three
supplementations were able to increase their percentage. There
is no information on the effect of these adipokines or
similar components in the intestinal effector lymphocytes, but
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FIGURE 6 | Venn diagram showing the distribution of the genera in the four
groups: Reference, Leptin, Adiponectin, and Whey Protein Concentrate (WPC)
(n = 6–12 pups).
previously, in leptin-supplemented rat pups, an increase of CD8+
proportion in both MLN and spleen was reported (19, 20).
Moreover, adiponectin and WPC administration also increased
CD8+ cells in the MLN (20) and spleen (19), respectively.
Siegmund et al. observed that ob/ob mice had fewer CD8+
in the IEL population and these cells also produced less
IFN-γ compared to wild-type mice (34), contributing to an
increase of the infections due to their role modulating the
immunity toward microbes (35). This fact together with our
present and previous results, strengthens the leptin role in
promoting the main effector cells in contact with the lumen
(CD8+ IEL). Interestingly, both adipokines act in different
ways, thus adiponectin and WPC supplementation increased
the percentage of CD8αβ+ cell subset, whereas leptin raised
that of CD8αα+ cell subset, leading to an increase in the
CD8αα+/CD8αβ+ ratio in the Leptin group compared to the
Reference group. The increase in CD8αα+ cell proportion could
be beneficial because this phenotype is more characteristic at
intestinal level (35), suggesting a local effect resulting from leptin
supplementation. Moreover, the three dietary interventions
did not modify the integrin αE+, CD62L+, or CD25+ cell
percentage after 21 days of supplementation, suggesting that
they do not have an impact on the intestinal homing
or activation pathways.
To further understand the impact of the studied
supplementations on the intestinal immune system, the
intestinal gene expression of some key molecules was assessed.
No effect was observed in the gene expression of the analyzed
TLR due to leptin or WPC supplementation, whereas a decrease
in TLR-2 and TLR-5 gene expression was observed due to
adiponectin supplementation. TLR-2 has an important role
in the recognition of molecules present in the membrane of
multiple pathogens, such as bacteria, virus, fungi and parasites
(36), whereas, TLR-5 detects the flagella of bacteria (37). Thus,
the decrease of these intestinal TLR could be related to the
anti-inflammatory properties attributed to adiponectin (38–40).
The TNF-α cytokine and the mucines, MUC-2, and MUC-
3, present in the small intestine act as an innate defense against
different pathogens, and a lack of these components result in
increased bacterial adhesion (41). MUC-2 gene was responsible
for the gel-forming mucins, whereas MUC-3 gene makes
membrane-bound mucins (42). Moreover, TNF-α regulates the
mucus layer, increasing expressions of pIgR and MUC-2; it
modulates tight-junctions, increasing intestinal permeability,
induces cell death, restitutes and regenerates the epithelium,
increasing cell migration and proliferation and interacts with
the immune system (43). The supplementation with leptin
or adiponectin during 21 days was able to increase the gene
expression of these three molecules compared to the Reference
group, suggesting a barrier reinforcement due to adipokines
in early life. The effect on MUC-2 was the only one found
already in the middle of the suckling period. In line with
these results, it has been described in rats that a perfusion
of leptin was able to increase the expression of MUC-2 and
MUC-3 and to stimulate mucus-secreting goblet cells (44, 45).
However, there is no information regarding whether adiponectin
affects these intestinal genes or modulates the intestinal epithelial
barrier. Gene expression of pIgR, Blimp-1 and FcRn is related
to intestinal function and maturation because their expression
changes during the suckling period. Whereas, the intestinal
pIgR is barely expressed during the suckling and increases after
weaning (46), the Blimp-1 and FcRn are highly expressed in
early life and decrease at weaning (47). In our study, although
the adipokines supplementation did not modify the proportion
of pIgR, they were able to decrease the gene expression of
FcRn on day 21, suggesting an early intestinal maturation.
Unexpectedly, a punctual increase on Blimp-1 mRNA levels
was observed after leptin supplementation. This fact triggers an
intricateness interpretation because Blimp-1 expression has been
described as being differential according to the intestinal section
evaluated (47).
The study of the gene expression related to tight junction
molecules showed that the adipokine supplementation did
not produce any significant change in any of the studied
days compared to the Reference group. Supporting this result,
it has been reported that, in mice, after an intraperitoneal
administration of 2µg/g of adiponectin, no change in colonic
Occludin and ZO-1 protein abundance at day 10 of life was
observed (33). Nevertheless, Kim et al. detected a decrease in
Occludin gene expression after the addition of 100 ng/mL of
leptin to Caco-2 BBe cell culture; however, it has to be taken
into account that these in vitro results should be confirmed
in vivo (48).
The effect of adipokine supplementation during the whole
suckling period on the gut microbiota composition was also
studied. The three studied components were able to decrease
the Proteobacteria phylum proportion. It has been described that
breast-fed infants had a lower abundance of Proteobacteria than
those fed with formula (49). In addition, in overweight/obese
mothers, who have high leptin concentration in their breast
milk, a lower abundance of Proteobacteria phylum in the infant
Frontiers in Immunology | www.frontiersin.org 10 October 2019 | Volume 10 | Article 2369
Grases-Pintó et al. Adipokines Influence Suckling Rat GALT and Microbiota
intestinal microbiota at 2 weeks old has also been observed
(50). Those results, together with ours, suggest that leptin
and adiponectin, adipokines present in breast milk, might be
components involved in the growth regulation of this phylum
in breast-fed infants. However, Rajala et al. described that leptin
receptor deficient mice (db/db) showed lower Bacteroidetes
and higher Firmicutes proportions than wild-type mice, results
not detected in the present study (51). Overall, in the early
life context and taking into account that in rats aged from
7 days old to 28 days old, the percentage of Proteobacteria
naturally decreases (27). So here, the reduction triggered by the
adipokine supplementation in this phylum could be related to
an enhancement of the gut microbiota maturation. Furthermore,
Proteobacteria was also related to inflammation and it is a risk
factor for necrotizing enterocolitis development in infants, thus a
depletion of this phylum could have a protective role against this
common pediatric disease (10).
Although previous studies are focused on modifications at the
phylum level, to our knowledge this is the first study to report the
effect of adipokines on a deeper level of taxonomy. The decrease
in the Proteobacteria phylum proportion was due to different
changes at family level. The three evaluated supplementations
were able to decrease the unclassified family from the RF32 order.
In addition, the leptin and WPC supplementations produced a
lower percentage of Desulfovibrionaceae and leptin nutritional
intervention was the only one that decreased the Alcaligenaceae
family. Moreover, the leptin administration during 21 days
was able to increase the Ruminococcaceae proportion and also
the unclassified family from the Clostridiales order. In line
with these results, Zhou et al. found a positive correlation
between plasmatic leptin and the Clostridiales order in male adult
mice (52). On the other hand, WPC was able to increase the
Prevotellaceae and Lactobacillaceae families, whereas a decrease
in Lachnospiraceae was detected. In accordance with that,
increased levels of Lactobacillus due to whey protein intake were
observed, specifically in obese donors (53). However, another
study reported in chicks, among other changes, an increase in
the relative proportion of the Lachnospiraceae and Bacteroidetes
families in the cecal microbiota after WPC administration (54).
Regarding the genus level, 16S rRNA gene sequencing
revealed a decrease in the Blautia genus in all supplemented
groups. Low levels of Blautia have been observed in children with
type 1 diabetes (55) or with Crohn’s disease (56, 57). Moreover,
rats supplemented with leptin showed higher Clostridium and
Dehalobacterium genera and lower levels of Holdemania and
Sutterella. Although Queipo-Ortuño et al. described a negative
correlation between serum leptin and Clostridium genus (58),
a higher concentration of the Sutterella genus was observed
in infants with autism (59, 60). Further studies considering
endocrine-gut-brain and leptin could be conducted to better
understand the role of this adipokine in this process. Moreover,
the adiponectin supplementation increased the proportion
of the Enterococcus genus and decreased the Roseburia and
Allobacterium genera. It is known that Enterococcus is an
opportunistic bacteria that has been associated with human celiac
disease (61); however, this is a preclinical study and further
studies are needed to shed light on this field. With regard to
the WPC supplementation, it was able to reduce the percentage
of the Anaerotruncus and Adlercreutzia genera and to increase
the proportion of the Dehalobacterium genus. Little is known
about the possible role of the Anaerotruncus genus, but Lau et al.
described a bacteraemia caused by Anaerotruncus colihominis
(62), so the fact that theWPC decreased this genus might suggest
a protective role in the newborn. Furthermore, children with
inflammatory bowel disease or patients with multiple sclerosis
showed a lower presence of Adlercreutzia compared with their
respective controls (63, 64).
On the other hand, other changes have been observed due to
leptin supplementation, such as new bacteria colonized the cecal
flora (Candidatus arthromitus) and afterWPC administration the
genus Lactococcus was detected.
The importance of the interaction between both the intestinal
immune system and microbiota is well-described. So, some of
the modifications in IEL composition or gene expression could
be due to the microbiota or vice-versa. For example, in mice
it has been reported that for the expansion of T cells from
the TCRαβ lineage, a normal microbial colonization of the
intestine is required (15). Moreover, Clostridia species showed an
important role in inducing Treg in the colonic mucosa of mice
(65). On the other hand, adaptive immunity seems to modulate
microbiota composition, as observed in B-cell-deficient mice,
where they had alterations in their microbiota, making it less
diverse. In addition, secretory IgA could modulate commensal
bacteria and also gut microbiota induce its secretion, this being
an example of the crosstalk between both of them (66, 67).
It has also been described that changes in mucin composition
could alter microbiota pattern and conversely, bacteria and their
metabolites could modify the mucus layer or even degrade it (68).
In addition to the composition of the microbiota, their
metabolites could also affect the immune system, and some
of the effects found in this work may be due to the changes
in the production of microbial metabolites due to the dietary
interventions with the adipokines. For example, short chain
fatty acids (SCFA), the most abundant molecules produced
by microbiota, have been described as being able to suppress
inflammation and increase Treg cells (69). Moreover, it has been
described that Lactobacilli tryptophan metabolites are ligands
of the aryl hydrocarbon receptor (AhR), which is a receptor
involved in the homeostasis of IEL (70). With reference to
adipokines, little is known about their effect on the microbial
metabolites. However, the mechanisms involved are even more
difficult to interpret as it was reported that SCFA could stimulate
leptin production and adiponectin expression in vitro (71, 72).
Overall, after demonstrating the influence of both adipokines on
microbiota composition, their metabolism should be explored in
terms of their impact on IEL development.
In conclusion, this study demonstrates that both leptin
and adiponectin supplementation throughout the suckling
period are able to modify the IEL composition by means of
increasing Tc TCRαβ+, NKT, and CD8+ lymphocyte proportions
and decreasing that of NK cells. Moreover, the intestinal
innate immunity was also enhanced by the increase in TNF-
α, MUC-2, and MUC-3 gene expression due to leptin and
adiponectin intervention. These adipokines also play a role in
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the maturation of the intestine by the early reduction of the
FcRn expression. In addition, we have reported for the first
time the effect of leptin and adiponectin on the gut microbiota
composition at the end of the suckling period. Overall, this study
reinforces the role of leptin and adiponectin in enhancing the
development of the effector immune system and microbiota in
the intestinal compartment.
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